SIRT4 protein suppresses tumor formation in genetic models of Myc-induced B cell lymphoma

Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis

DeBerardinis, R. J., Mancuso, A., Daikhin, E., Nissim, I., Yudkoff, M., Wehrli, S., & Thompson, C. B. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709747104 · Cited by 2,622 · see citing works

c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism

Gao, P., Tchernyshyov, I., Chang, T.-C., Lee, Y.-S., Kita, K., Ochi, T., Zeller, K. I., De Marzo, A. M., Van Eyk, J. E., Mendell, J. T., et al. (2009) · Nature · doi:10.1038/nature07823 · Cited by 2,124 · see citing works

Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction

Wise, D. R., DeBerardinis, R. J., Mancuso, A., Sayed, N., Zhang, X.-Y., Pfeiffer, H. K., Nissim, I., Daikhin, E., Yudkoff, M., McMahon, S. B., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810199105 · Cited by 2,001 · see citing works

The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice

Adams, J. M., Harris, A. W., Pinkert, C. A., Corcoran, L. M., Alexander, W. S., Cory, S., Palmiter, R. D., & Brinster, R. L. (1985) · Nature · doi:10.1038/318533a0 · Cited by 1,778 · see citing works

Glutamine addiction: a new therapeutic target in cancer

Wise, D. R., & Thompson, C. B. (2010) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2010.05.003 · Cited by 1,770 · see citing works

Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity

Weinberg, F., Hamanaka, R., Wheaton, W. W., Weinberg, S., Joseph, J., Lopez, M., Kalyanaraman, B., Mutlu, G. M., Budinger, G. R. S., & Chandel, N. S. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1003428107 · Cited by 1,742 · see citing works

Recent progress in the biology and physiology of sirtuins

Finkel, T., Deng, C., & Mostoslavsky, R. (2009) · Nature · doi:10.1038/nature08197 · Cited by 1,484 · see citing works

Mammalian sirtuins—emerging roles in physiology, aging, and calorie restriction

Haigis, M. C., & Guarente, L. P. (2006) · Genes & Development · doi:10.1101/gad.1467506 · Cited by 1,295 · see citing works

SIRT4 Inhibits Glutamate Dehydrogenase and Opposes the Effects of Calorie Restriction in Pancreatic β Cells

Haigis, M. C., Mostoslavsky, R., Haigis, K. M., Fahie, K., Christodoulou, D. C., Murphy, A. J., Valenzuela, D. M., Yancopoulos, G. D., Karow, M., Blander, G., et al. (2006) · Cell · doi:10.1016/j.cell.2006.06.057 · Cited by 1,162 · see citing works

Glucose-Independent Glutamine Metabolism via TCA Cycling for Proliferation and Survival in B Cells

Le, A., Lane, A. N., Hamaker, M., Bose, S., Gouw, A., Barbi, J., Tsukamoto, T., Rojas, C. J., Slusher, B. S., Zhang, H., et al. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2011.12.009 · Cited by 1,095 · see citing works

Targeting metabolic transformation for cancer therapy

Tennant, D. A., Durán, R. V., & Gottlieb, E. (2010) · Nature reviews. Cancer · doi:10.1038/nrc2817 · Cited by 1,057 · see citing works

MYC-Induced Cancer Cell Energy Metabolism and Therapeutic Opportunities

Dang, C. V., Le, A., & Gao, P. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-0889 · Cited by 934 · see citing works

Modelling Myc inhibition as a cancer therapy

Soucek, L., Whitfield, J. R., Martins, C. P., Finch, A. J., Murphy, D. J., Sodir, N. M., Karnezis, A. N., Swigart, L. B., Nasi, S., & Evan, G. I. (2008) · Nature · doi:10.1038/nature07260 · Cited by 822 · see citing works

Targeting Mitochondrial Glutaminase Activity Inhibits Oncogenic Transformation

Wang, J.-B., Erickson, J. W., Fuji, R., Ramachandran, S., Gao, P., Dinavahi, R., Wilson, K. F., Ambrosio, A. L. B., Dias, S. M. G., Dang, C. V., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.08.009 · Cited by 821 · see citing works

Deficiency in glutamine but not glucose induces MYC-dependent apoptosis in human cells

Yuneva, M., Zamboni, N., Oefner, P., Sachidanandam, R., & Lazebnik, Y. (2007) · The Journal of Cell Biology · doi:10.1083/jcb.200703099 · Cited by 690 · see citing works

Regulation of Glutaminase Activity and Glutamine Metabolism

Curthoys, N. P., & Watford, M. (1995) · Annual Review of Nutrition · doi:10.1146/annurev.nu.15.070195.001025 · Cited by 643 · see citing works

The mTORC1 Pathway Stimulates Glutamine Metabolism and Cell Proliferation by Repressing SIRT4

Csibi, A., Fendt, S.-M., Li, C., Poulogiannis, G., Choo, A. Y., Chapski, D. J., Jeong, S. M., Dempsey, J. M., Parkhitko, A., Morrison, T., et al. (2013) · Cell · doi:10.1016/j.cell.2013.04.023 · Cited by 586 · see citing works

2-Deoxy- d -glucose Increases the Efficacy of Adriamycin and Paclitaxel in Human Osteosarcoma and Non-Small Cell Lung Cancers In Vivo

Maschek, G., Savaraj, N., Priebe, W., Braunschweiger, P. G., Hamilton, K., Tidmarsh, G. F., Young, L. R. D., & Lampidis, T. J. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3294 · Cited by 452 · see citing works

Genetic dissection of the miR-17∼92 cluster of microRNAs in Myc-induced B-cell lymphomasPreprint

Mu, P., Han, Y.-C., Betel, D., Yao, E. S., Squatrito, M., Ogrodowski, P., de Stanchina, E., D’Andrea, A., Sander, C., & Ventura, A. (2009) · Genes & Development · doi:10.1101/gad.1872909 · Cited by 449 · see citing works

SIRT4 Has Tumor-Suppressive Activity and Regulates the Cellular Metabolic Response to DNA Damage by Inhibiting Mitochondrial Glutamine Metabolism

Jeong, S. M., Xiao, C., Finley, L. W. S., Lahusen, T., Souza, A. L., Pierce, K., Li, Y.-H., Wang, X., Laurent, G., German, N. J., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.02.024 · Cited by 445 · see citing works

Glioblastoma Cells Require Glutamate Dehydrogenase to Survive Impairments of Glucose Metabolism or Akt Signaling

Yang, C., Sudderth, J., Dang, T. T., Bachoo, R. G., McDonald, J. G., & DeBerardinis, R. J. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-2266 · Cited by 425 · see citing works

Rethinking the Warburg Effect with Myc Micromanaging Glutamine Metabolism

Dang, C. V. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3556 · Cited by 379 · see citing works

Novel mechanism of inhibition of rat kidney-type glutaminase by bis-2-(5-phenylacetamido-1,2,4-thiadiazol-2-yl)ethyl sulfide (BPTES)

Robinson, M. M., McBryant, S. J., Tsukamoto, T., Rojas, C. J., Ferraris, D. V., Hamilton, S. K., Hansen, J. C., & Curthoys, N. P. (2007) · Biochemical Journal · doi:10.1042/bj20070039 · Cited by 344 · see citing works

Glucose Addiction of TSC Null Cells Is Caused by Failed mTORC1-Dependent Balancing of Metabolic Demand with Supply

Choo, A. Y., Kim, S. G., Heiden, M. G. V., Mahoney, S. J., Vu, H., Yoon, S.-O., Cantley, L. C., & Blenis, J. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.05.007 · Cited by 248 · see citing works

Puma and to a lesser extent Noxa are suppressors of Myc-induced lymphomagenesis

Michalak, E. M., Jansen, E. S., Happo, L., Cragg, M. S., Tai, L., Smyth, G. K., Strasser, A., Adams, J. M., & Scott, C. L. (2009) · Cell Death and Differentiation · doi:10.1038/cdd.2008.195 · Cited by 152 · see citing works

Therapeutic Targeting of Myc-Reprogrammed Cancer Cell MetabolismPreprint

Dang, C. V. (2011) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2011.76.011296 · Cited by 104 · see citing works

Addition of Either Lonidamine or Granulocyte Colony-Stimulating Factor Does Not Improve Survival in Early Breast Cancer Patients Treated With High-Dose Epirubicin and Cyclophosphamide

Papaldo, P., Lopez, M., Cortesi, E., Cammilluzzi, E., Antimi, M., Terzoli, E., Lepidini, G., Vici, P., Barone, C. A., Ferretti, G., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.03.034 · Cited by 78 · see citing works

Mitochondria and cancer

Vyas, S., Zaganjor, E., & Haigis, M. C. (2016) · Cell · doi:10.1016/j.cell.2016.07.002 · Cited by 1,735 · see citing works

The multifaceted functions of sirtuins in cancer

Chalkiadaki, A., & Guarente, L. (2015) · Nature reviews. Cancer · doi:10.1038/nrc3985 · Cited by 501 · see citing works

The Interplay of Reactive Oxygen Species, Hypoxia, Inflammation, and Sirtuins in Cancer Initiation and Progression

Tafani, M., Sansone, L., Limana, F., Arcangeli, T., Santis, E. D., Polese, M., Fini, M., & Russo, M. A. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/3907147 · Cited by 371 · see citing works

The Roles of Histone Deacetylases and Their Inhibitors in Cancer Therapy

Guo, L., Tian, Y., & Zhu, W. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.576946 · Cited by 358 · see citing works

SIRT4 is a lysine deacylase that controls leucine metabolism and insulin secretion

Anderson, K. A., Huynh, F. K., Fisher-Wellman, K., Stuart, J. D., Peterson, B. S., Douros, J. D., Wagner, G. R., Thompson, J. W., Madsen, A. S., Green, M. F., et al. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.03.003 · Cited by 326 · see citing works

The Mitochondrial Acylome Emerges: Proteomics, Regulation by Sirtuins, and Metabolic and Disease Implications

Carrico, C., Meyer, J. G., He, W., Gibson, B. W., & Verdin, E. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.01.016 · Cited by 331 · see citing works

The Warburg Effect 97 Years after Its Discovery

Pascale, R. M., Calvisi, D. F., Simile, M. M., Feo, C. F., & Feo, F. (2020) · Cancers · doi:10.3390/cancers12102819 · Cited by 304 · see citing works

Sirtuins: guardians of mammalian healthspan

Giblin, W., Skinner, M. E., & Lombard, D. B. (2014) · Trends in Genetics · doi:10.1016/j.tig.2014.04.007 · Cited by 280 · see citing works

Dual Tumor Suppressor and Tumor Promoter Action of Sirtuins in Determining Malignant Phenotype

Carafa, V., Altucci, L., & Nebbioso, A. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00038 · Cited by 183 · see citing works

The role of mitochondrial sirtuins in health and disease

Osborne, B., Bentley, N. L., Montgomery, M. K., & Turner, N. A. (2016) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.04.197 · Cited by 179 · see citing works

Warburg and Beyond: The Power of Mitochondrial Metabolism to Collaborate or Replace Fermentative Glycolysis in Cancer

Cassim, S., Vučetić, M., Ždralević, M., & Pouysségur, J. (2020) · Cancers · doi:10.3390/cancers12051119 · Cited by 176 · see citing works

Mitochondrial Sirtuins and Their Relationships with Metabolic Disease and Cancer

Kumar, S., & Lombard, D. B. (2014) · Antioxidants and Redox Signaling · doi:10.1089/ars.2014.6213 · Cited by 158 · see citing works

ABC, GCB, and Double-Hit Diffuse Large B-Cell Lymphoma: Does Subtype Make a Difference in Therapy Selection?

Nowakowski, G. S., & Czuczman, M. S. (2015) · American Society of Clinical Oncology Educational Book · doi:10.14694/edbook_am.2015.35.e449 · Cited by 150 · see citing works

Emerging Roles for SIRT5 in Metabolism and Cancer

Bringman, L. R., Guo, A. H., Lyssiotis, C. A., & Lombard, D. B. (2017) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7264 · Cited by 140 · see citing works

MicroRNA-15b regulates mitochondrial ROS production and the senescence-associated secretory phenotype through sirtuin 4/SIRT4

Lang, A., Grether‐Beck, S., Singh, M., Kuck, F., Jakob, S., Kefalas, A., Altinoluk-Hambüchen, S., Graffmann, N., Schneider, M., Lindecke, A., et al. (2016) · Aging · doi:10.18632/aging.100905 · Cited by 138 · see citing works

SIRT4 inhibits malignancy progression of NSCLCs, through mitochondrial dynamics mediated by the ERK-Drp1 pathway

Fu, L., Dong, Q., He, J., Wang, X., Xing, J., Wang, E.-H., Qiu, X., & Li, Q. (2016) · Oncogene · doi:10.1038/onc.2016.425 · Cited by 135 · see citing works

The Roles of Mitochondrial SIRT4 in Cellular Metabolism

Min, Z., Gao, J., & Yu, Y. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00783 · Cited by 134 · see citing works

Sirtuin‐dependent epigenetic regulation in the maintenance of genome integrity

Bosch‐Presegué, L., & Vaquero, A. (2015) · The FEBS Journal · doi:10.1111/febs.13053 · Cited by 132 · see citing works

A glutamine tug-of-war between cancer and immune cells: recent advances in unraveling the ongoing battle

Wang, B., Pei, J., Xu, S.-N., Liu, J., & Yu, J.-M. (2024) · Journal of experimental & clinical cancer research : CR · doi:10.1186/s13046-024-02994-0 · Cited by 129 · see citing works

The Current State of NAD+‐Dependent Histone Deacetylases (Sirtuins) as Novel Therapeutic Targets

Schiedel, M., Robaa, D., Rumpf, T., Sippl, W., & Jung, M. (2017) · Medicinal Research Reviews · doi:10.1002/med.21436 · Cited by 122 · see citing works

The roles of sirtuins family in cell metabolism during tumor development

Zhu, S., Dong, Z., Ke, X., Hou, J., Zhao, E., Zhang, K., Wang, F., Yang, L., Xiang, Z., & Cui, H. (2018) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2018.11.003 · Cited by 113 · see citing works

Sirtuins' control of autophagy and mitophagy in cancer

Aventaggiato, M., Vernucci, E., Barreca, F., Russo, M. A., & Tafani, M. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107748 · Cited by 103 · see citing works

Targeting sirtuins for cancer therapy: epigenetics modifications and beyond

Shen, H., Qi, X., Hu, Y., Wang, Y., Zhang, J., Liu, Z., & Qin, Z. (2024) · Theranostics · doi:10.7150/thno.100667 · Cited by 95 · see citing works

MYC regulates ribosome biogenesis and mitochondrial gene expression programs through its interaction with host cell factor–1

Popay, T. M., Wang, J., Adams, C. M., Howard, G. C., Codreanu, S. G., Sherrod, S. D., MCLEAN, J. A. J., Thomas, L. R., Lorey, S. L., Machida, Y., et al. (2021) · eLife · doi:10.7554/elife.60191 · Cited by 90 · see citing works

Who watches the watchmen? Regulation of the expression and activity of sirtuins

Buler, M., Andersson, U., & Hakkola, J. (2016) · The FASEB Journal · doi:10.1096/fj.201600410rr · Cited by 84 · see citing works

Sirt4: A Multifaceted Enzyme at the Crossroads of Mitochondrial Metabolism and Cancer

Tomaselli, D., Steegborn, C., Mai, A., & Rotili, D. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00474 · Cited by 80 · see citing works

Interplay between sirtuins, MYC and hypoxia-inducible factor in cancer-associated metabolic reprogramming

Zwaans, B. M. M., & Lombard, D. B. (2014) · Disease Models & Mechanisms · doi:10.1242/dmm.016287 · Cited by 81 · see citing works

Mitochondrial Sirtuins in Cancer: Emerging Roles and Therapeutic Potential

George, J., & Ahmad, N. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-2733 · Cited by 81 · see citing works

MYC Rules: Leading Glutamine Metabolism toward a Distinct Cancer Cell Phenotype

Tambay, V., Raymond, V., & Bilodeau, M. (2021) · Cancers · doi:10.3390/cancers13174484 · Cited by 82 · see citing works

Update on Burkitt Lymphoma

Dunleavy, K. M., Little, R. F., & Wilson, W. H. (2016) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2016.07.009 · Cited by 80 · see citing works

Mitochondrial Function, Metabolic Regulation, and Human Disease Viewed through the Prism of Sirtuin 4 (SIRT4) Functions

Betsinger, C. N., & Cristea, I. M. (2019) · Journal of Proteome Research · doi:10.1021/acs.jproteome.9b00086 · Cited by 80 · see citing works

Dysregulated glycolysis as an oncogenic event

Mikawa, T., LLeonart, M. E., Takaori‐Kondo, A., Inagaki, N., Yokode, M., & Kondoh, H. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-1840-3 · Cited by 80 · see citing works

Sirtuins and Cancer: Role in the Epithelial‐Mesenchymal Transition

Palmirotta, R., Cives, M., Della‐Morte, D., Capuani, B., Lauro, D., Guadagni, F., & Silvestris, F. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/3031459 · Cited by 78 · see citing works

Sirtuin 4 Depletion Promotes Hepatocellular Carcinoma Tumorigenesis Through Regulating Adenosine‐Monophosphate–Activated Protein Kinase Alpha/Mammalian Target of Rapamycin Axis in Mice

Wang, Y., Du, L., Liang, X., Meng, P., Bi, L., Wang, Y., Wang, C., & Tang, B. (2018) · Hepatology · doi:10.1002/hep.30421 · Cited by 77 · see citing works

SIRT3 and SIRT4 are mitochondrial tumor suppressor proteins that connect mitochondrial metabolism and carcinogenesis

Zhu, Y., Yan, Y., Principe, D. R., Zou, X., Vassilopoulos, A., & Gius, D. R. (2014) · Cancer & Metabolism · doi:10.1186/2049-3002-2-15 · Cited by 76 · see citing works

Sirtuins in Cancer: a Balancing Act between Genome Stability and Metabolism

Jeong, S. M., & Haigis, M. C. (2015) · Molecules and Cells · doi:10.14348/molcells.2015.0167 · Cited by 74 · see citing works

The sirtuin family in cancer

Costa‐Machado, L. F., & Fernández-Marcos, P. J. (2019) · Cell Cycle · doi:10.1080/15384101.2019.1634953 · Cited by 66 · see citing works

SIRT4 and Its Roles in Energy and Redox Metabolism in Health, Disease and During Exercise

Han, Y., Zhou, S., Coetzee, S., & Chen, A. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.01006 · Cited by 69 · see citing works

The pleiotropic effects of the glutamate dehydrogenase (GDH) pathway in Saccharomyces cerevisiae

Mara, P., Fragiadakis, G. S., Gkountromichos, F., & Alexandraki, D. (2018) · Microbial Cell Factories · doi:10.1186/s12934-018-1018-4 · Cited by 65 · see citing works

CtBP maintains cancer cell growth and metabolic homeostasis via regulating SIRT4

Wang, L., Zhou, H., Wang, Y., Cui, G., & Di, L.-J. (2015) · Cell Death and Disease · doi:10.1038/cddis.2014.587 · Cited by 62 · see citing works

SIRT4 regulates cancer cell survival and growth after stress

Jeong, S. M., Hwang, S., & Seong, R. H. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.01.078 · Cited by 61 · see citing works

Natural Products as Modulators of Sirtuins

Karaman, B., Sippl, W., & Ntie‐Kang, F. (2020) · Molecules · doi:10.3390/molecules25143287 · Cited by 59 · see citing works

Sirtuin-4 (SIRT4) is downregulated and associated with some clinicopathological features in gastric adenocarcinoma

Huang, G., Cui, F., Yu, F., Lu, H., Zhang, M., Tang, H., & Peng, Z. (2015) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2015.04.013 · Cited by 58 · see citing works

SIRT4 inhibits the proliferation, migration, and invasion abilities of thyroid cancer cells by inhibiting glutamine metabolism

Chen, Z., Lin, J., Feng, S., Chen, X., Huang, H., Wang, C., Yu, Y., He, Y., Han, S., Zheng, L., et al. (2019) · OncoTargets and Therapy · doi:10.2147/ott.s189536 · Cited by 51 · see citing works

Rethinking glutamine metabolism and the regulation of glutamine addiction by oncogenes in cancer

Ni, R., Li, Z., Li, L., Peng, D., Ming, Y., Li, L., & Liu, Y. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1143798 · Cited by 55 · see citing works

Sirtuin-4 (SIRT4), a therapeutic target with oncogenic and tumor-suppressive activity in cancer

Huang, G., & Zhu, G. (2018) · OncoTargets and Therapy · doi:10.2147/ott.s157724 · Cited by 52 · see citing works

Clinical and therapeutic significance of sirtuin-4 expression in colorectal cancer

Huang, G., Cheng, J., Yu, F., Liu, X., Yuan, C., Liu, C., Chen, X.-L., & Peng, Z. (2016) · Oncology Reports · doi:10.3892/or.2016.4685 · Cited by 52 · see citing works

SIRT4 acts as a tumor suppressor in gastric cancer by inhibiting cell proliferation, migration, and invasion

Sun, H., Huang, D., Liu, G., Jian, F., Zhu, J., & Zhang, L. (2018) · OncoTargets and Therapy · doi:10.2147/ott.s156143 · Cited by 51 · see citing works

Targeting aberrant cancer metabolism – The role of sirtuins

Kleszcz, R., Paluszczak, J., & Baer‐Dubowska, W. (2015) · Pharmacological Reports · doi:10.1016/j.pharep.2015.03.021 · Cited by 49 · see citing works

HIF-1α-dependent miR-424 induction confers cisplatin resistance on bladder cancer cells through down-regulation of pro-apoptotic UNC5B and SIRT4

Yu, M., Ozaki, T., Sun, D., Xing, H., Wei, B., An, J., Yang, J., Gao, Y., Liu, S., Kong, C., et al. (2020) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-020-01613-y · Cited by 45 · see citing works

Double-hit lymphomas: current paradigms and novel treatment approaches

Dunleavy, K. M. (2014) · Hematology · doi:10.1182/asheducation-2014.1.107 · Cited by 46 · see citing works

Inactivation of Lsd1 triggers senescence in trophoblast stem cells by induction of Sirt4

Castex, J., Willmann, D., Kanouni, T., Arrigoni, L., Li, Y., Friedrich, M. E., Schleicher, M., Wöhrle, S., Pearson, M. A., Kraut, N., et al. (2017) · Cell Death and Disease · doi:10.1038/cddis.2017.48 · Cited by 46 · see citing works

Chemical and Physiological Features of Mitochondrial Acylation

Ringel, A. E., Tucker, S. A., & Haigis, M. C. (2018) · Molecular Cell · doi:10.1016/j.molcel.2018.10.023 · Cited by 40 · see citing works

Poly(ADP-Ribose) Polymerases in Host-Pathogen Interactions, Inflammation, and Immunity

Brady, P. N., Goel, A., & Johnson, M. A. (2019) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00038-18 · Cited by 58 · see citing works

The role of mammalian sirtuins in cancer metabolism

Sebastián, C., & Mostoslavsky, R. (2015) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2015.07.008 · Cited by 39 · see citing works

Aggressive B cell Lymphoma: Optimal Therapy for MYC-positive, Double-Hit, and Triple-Hit DLBCL

Dunleavy, K. M. (2015) · Current Treatment Options in Oncology · doi:10.1007/s11864-015-0374-0 · Cited by 37 · see citing works

Targeting MYC Dependence by Metabolic Inhibitors in Cancer

Sabnis, H. S., Somasagara, R. R., & Bunting, K. D. (2017) · Genes · doi:10.3390/genes8040114 · Cited by 36 · see citing works

Metabolic mechanisms orchestrated by Sirtuin family to modulate inflammatory responses

Li, X., Li, Y., Hao, Q., Jin, J., & Wang, Y. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1448535 · Cited by 35 · see citing works

Overexpression of SIRT4 inhibits the proliferation of gastric cancer cells through cell cycle arrest

Hu, Y., Lin, J., Lin, Y., Chen, X., Zhu, G., & Huang, G. (2018) · Oncology Letters · doi:10.3892/ol.2018.9877 · Cited by 32 · see citing works

Subcellular Localization and Mitotic Interactome Analyses Identify SIRT4 as a Centrosomally Localized and Microtubule Associated Protein

Bergmann, L., Lang, A., Bross, C., Altinoluk-Hambüchen, S., Fey, I., Overbeck, N., Stefanski, A., Wiek, C., Kefalas, A., Verhülsdonk, P., et al. (2020) · Cells · doi:10.3390/cells9091950 · Cited by 32 · see citing works

The Mechanistic Roles of Sirtuins in Breast and Prostate Cancer

Onyiba, C. I., Scarlett, C. J., & Weidenhofer, J. (2022) · Cancers · doi:10.3390/cancers14205118 · Cited by 31 · see citing works

Mitochondrial sirtuins in stem cells and cancer

Jaiswal, A., Xudong, Z., Ju, Z., & Saretzki, G. C. (2021) · FEBS Journal · doi:10.1111/febs.15879 · Cited by 29 · see citing works

Targeting respiratory complex I to prevent the Warburg effect

Vatrinet, R., Iommarini, L., Kurelac, I., Luise, M. D., Gasparre, G., & Porcelli, A. M. (2015) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2015.01.017 · Cited by 29 · see citing works

Double hit lymphoma: from biology to therapeutic implications

Burotto, M., Berkovits, A., & Dunleavy, K. M. (2016) · Expert Review of Hematology · doi:10.1080/17474086.2016.1182858 · Cited by 28 · see citing works

Regulation of Adaptive Immune Cells by Sirtuins

Warren, J. L., & MacIver, N. J. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00466 · Cited by 28 · see citing works

The role of compartmentalized signaling pathways in the control of mitochondrial activities in cancer cells

Rinaldi, L., Donne, R. D., Borzacchiello, D., Insabato, L., & Feliciello, A. (2018) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2018.04.004 · Cited by 26 · see citing works

Regulation of Cancer and Cancer-Related Genes via NAD +

Sharif, T., Martell, E., Dai, C., Ghassemi-Rad, M. S., Kennedy, B. E., Lee, P. W. K., & Gujar, S. A. (2018) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7478 · Cited by 25 · see citing works

Intersections between mitochondrial sirtuin signaling and tumor cell metabolism

Herrera, K. N. G., Lee, J. J., & Haigis, M. C. (2015) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238.2015.1031879 · Cited by 24 · see citing works

Mammalian Sirtuins SIRT4 and SIRT7

Li, S., & Zheng, W. (2018) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2017.11.001 · Cited by 24 · see citing works

Knockout of SIRT4 decreases chemosensitivity to 5‑FU in colorectal cancer cells

Zhu, Y., Wang, G., Li, X., Wang, T., Weng, M., & Zhang, Y. (2018) · Oncology Letters · doi:10.3892/ol.2018.8850 · Cited by 24 · see citing works

Metabolic Reprogramming and Potential Therapeutic Targets in Lymphoma

Pang, Y., Lu, T., Xu-Monette, Z. Y., & Young, K. H. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065493 · Cited by 25 · see citing works

Impact of Sirtuin Enzymes on the Altered Metabolic Phenotype of Malignantly Transformed Cells

Gaál, Z., & Csernoch, L. J. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00045 · Cited by 22 · see citing works

Functions of mammalian SIRT4 in cellular metabolism and research progress in human cancer (Review)

Wang, C., Liu, Y., Zhu, Y., & Kong, C. (2020) · Oncology Letters · doi:10.3892/ol.2020.11872 · Cited by 22 · see citing works

Tumor-suppressive function of SIRT4 in neuroblastoma through mitochondrial damage

Wang, Y., Guo, Y., Gao, J., & Yuan, X. (2018) · Cancer Management and Research · doi:10.2147/cmar.s172509 · Cited by 20 · see citing works

Research Progress of Sirtuin4 in Cancer

Bai, Y., Yang, J., Cui, Y., Yao, Y., Wu, F., Liu, C., Fan, X., & Zhang, Y. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2020.562950 · Cited by 20 · see citing works

Challenges and Opportunities for High-grade B-Cell Lymphoma With MYC and BCL2 and/or BCL6 Rearrangement (Double-hit Lymphoma)

Zeng, D., Desai, A. P., Yan, F., Gong, T., Ye, H., Ahmed, M., Nomie, K. J., Romaguera, J. E., Champlin, R. E., Li, S., et al. (2018) · American Journal of Clinical Oncology · doi:10.1097/coc.0000000000000427 · Cited by 18 · see citing works

Sirtuins in B lymphocytes metabolism and function

Ghirotto, B., Terra, F. F., Câmara, N. O. S., & Basso, P. J. (2019) · World Journal of Experimental Medicine · doi:10.5493/wjem.v9.i1.1 · Cited by 17 · see citing works

Amino acid metabolism: challenges and opportunities for the therapeutic treatment of leukemia and lymphoma

Liao, P., Chang, N., Xu, B., Qiu, Y., Wang, S., Zhou, L., He, Y., Xie, X., & Li, Y. (2022) · Immunology and Cell Biology · doi:10.1111/imcb.12557 · Cited by 16 · see citing works

SIRT4 loss reprograms intestinal nucleotide metabolism to support proliferation following perturbation of homeostasis

Tucker, S. A., Hu, S.-H., Vyas, S., Park, A., Joshi, S., Inal, A., Lam, T., Tan, E., Haigis, K. M., & Haigis, M. C. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.113975 · Cited by 18 · see citing works

The Role of NAD+, SIRTs Interactions in Stimulating and Counteracting Carcinogenesis

Podyacheva, E., & Toropova, Y. G. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24097925 · Cited by 14 · see citing works

Metabolic Gatekeepers of Pathological B Cell Activation

Sadras, T., Chan, L. N., Xiao, G., & Müschen, M. (2020) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathol-061020-050135 · Cited by 14 · see citing works

A glance at the actual role of glutamine metabolism in thyroid tumorigenesis

Abooshahab, R., Hooshmand, K., Razavi, F., Dass, C. R., & Hedayati, M. (2021) · EXCLI journal · doi:10.17179/excli2021-3826 · Cited by 14 · see citing works

SIRT1-SIRT7 Expression in Patients with Lymphoproliferative Disorders Undergoing Hematopoietic Stem Cell Mobilization

Nowicki, M., Wierzbowska, A., Stec‐Martyna, E., Kulczycka-Wojdala, D., Nowicki, G., & Szmigielska‐Kapłon, A. (2022) · Cancers · doi:10.3390/cancers14051213 · Cited by 12 · see citing works

Sirtuins, Healthspan, and Longevity in Mammals

Giblin, W., & Lombard, D. B. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-411596-5.00003-4 · Cited by 12 · see citing works

Amino acids in hematologic malignancies: Current status and future perspective

Wang, M., Zhao, A., Li, M., & Niu, T. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1113228 · Cited by 11 · see citing works

Circular RNA OMA1 regulates the progression of breast cancer via modulation of the miR‑1276/SIRT4 axis

Xu, L., Xu, K., Xiang, L., & Yan, J. (2021) · Molecular Medicine Reports · doi:10.3892/mmr.2021.12367 · Cited by 10 · see citing works

Sirtuin insights: bridging the gap between cellular processes and therapeutic applications

Kamal, S., Babar, S., Ali, W., Rehman, K., Hussain, A., & Akash, M. S. H. (2024) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-024-03263-9 · Cited by 8 · see citing works

Histone Deacetylase Inhibitors Promote the Anticancer Activity of Cisplatin: Mechanisms and Potential

Zhou, Y., Luo, Q., Gu, L., Tian, X., Zhao, Y., Zhang, Y., & Wang, F. (2025) · Pharmaceuticals · doi:10.3390/ph18040563 · Cited by 9 · see citing works

Sirtuins Function as the Modulators in Aging-related Diseases in Common or Respectively

Wang, Q., & Guo, S. (2015) · Chinese Medical Journal · doi:10.4103/0366-6999.158375 · Cited by 8 · see citing works

Development of a mitochondrial sirtuin 4 FRET assay based on its activity for removing 3-hydroxy-3-methylglutaryl (HMG) modification

Li, Y., Zhao, Y., Cao, Z., Wang, J., Liu, T., Li, Y., Wang, Y., & He, B. (2021) · RSC Advances · doi:10.1039/d0ra09424b · Cited by 7 · see citing works

Multiomic analysis of lactylation and mitochondria-related genes in hepatocellular carcinoma identified MRPL3 as a new prognostic biomarker

Xing, W., Zhou, Y., Long, Q., Yi, N., Wang, G., Shi, R., Huang, J., Yin, X., Zhu, T., & Cao, S. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2024.1511958 · Cited by 7 · see citing works

Sirtuin 6 Is a Critical Epigenetic Regulator of Cancer

Raghu, S., Prabhashankar, A. B., Shivanaiah, B., Tripathi, E., & Sundaresan, N. R. (2022) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-3-031-07634-3_10 · Cited by 7 · see citing works

Advances of SIRT4 in cancer metabolism and therapy

Yue, X., Shi, Y., & Luo, Q. (2023) · Pediatric Discovery · doi:10.1002/pdi3.17 · Cited by 6 · see citing works

Lessons from Using Genetically Engineered Mouse Models of MYC-Induced Lymphoma

Winkler, R., Piskor, E.-M., & Kosan, C. (2022) · Cells · doi:10.3390/cells12010037 · Cited by 6 · see citing works

The Role of the Sirtuin Family Histone Deacetylases in Acute Myeloid Leukemia—A Promising Road Ahead

Strzałka, P., Krawiec, K. M., Wiśnik, A., Jarych, D., Czemerska, M., Zawlik, I., Pluta, A., & Wierzbowska, A. (2025) · Cancers · doi:10.3390/cancers17061009 · Cited by 5 · see citing works

Mitochondrial Sirtuins

Yang, W., van de Ven, R. A. H., & Haigis, M. C. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-813499-3.00008-3 · Cited by 4 · see citing works

Strong Involvement of Classical Histone Deacetylases and Mechanistically Distinct Sirtuins in Bellicose Cancers

Ganai, S. A. (2020) · Springer eBooks · doi:10.1007/978-981-15-8179-3_4 · Cited by 4 · see citing works

Sirtuins and cellular metabolism in cancers

Dong, Z., & Cui, H. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822467-0.00008-5 · Cited by 3 · see citing works

Genetic Interactions of Mitochondrial Sirtuins in Brain Tumorigenesis

Haq, M. F. U., Kayani, M. A., Arshad, T., Anwar, R. A. H., Saeed, N., Shafique, R., Abbasi, S. F., Ahmed, M. W., & Mahjabeen, I. (2022) · Future Oncology · doi:10.2217/fon-2021-0264 · Cited by 3 · see citing works

Molecular, Cellular, and Physiological Characterization of Sirtuin 7 (SIRT7)

Shin, J. J., & Chen, D. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-3667-0_18 · Cited by 3 · see citing works

Metabolic block

Seton-Rogers, S. E. (2013) · Nature reviews. Cancer · doi:10.1038/nrc3547

SIRT4 Has Tumor-Suppressive Activity and Regulates the Cellular Metabolic Response to DNA Damage by Inhibiting Mitochondrial Glutamine Metabolism

Jeong, S. M., Xiao, C., Finley, L. W. S., Lahusen, T., Souza, A. L., Pierce, K., Li, Y.-H., Wang, X., Laurent, G., German, N. J., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.02.024 · Cited by 445 · see citing works

SIRT4 Controls the Cellular Metabolic Response to DNA Damage

(2013) · Cancer Discovery · doi:10.1158/2159-8290.cd-rw2013-079

Oncogenes and Tumor Suppressors Regulate Glutamine Metabolism in Cancer Cells

Kim, M., & Kim, H. (2013) · Journal of Cancer Prevention · doi:10.15430/jcp.2013.18.3.221 · Cited by 54 · see citing works

ATF4 Regulates MYC-Mediated Neuroblastoma Cell Death upon Glutamine Deprivation

Qing, G., Li, B., Vu, A., Skuli, N., Walton, Z. E., Liu, X., Mayes, P. A., Wise, D. R., Thompson, C. B., Maris, J. M., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.09.021 · Cited by 375 · see citing works